13.94  -0.525 (-3.63%)		06-09 16:00
Open: 14.59 High: 15.155 Volume: 1,908,380		Pre. Close: 14.465 Low: 13.68 Market Cap: 951(M)

Short term
Mid term
Targets	6-month :	18.39	1-year :	21.48
Resists	First :	15.75	Second :	18.39
Pivot price	13.07
Supports	First :	12.14	Second :	9.92
MAs	MA(5) :	14.32	MA(20) :	12.54
	MA(100) :	18.27	MA(250) :	23.91
MACD	MACD :	0.4	Signal :	0
%K %D	K(14,3) :	71.5	D(3) :	78.7
RSI	RSI(14): 56.1
52-week	High :	35.58	Low :	9.92

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ QDEL ] has closed below upper band by 30.0%. Bollinger Bands are 33.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	15.18 - 15.25	15.25 - 15.32
Low:	13.52 - 13.59	13.59 - 13.65
Close:	13.83 - 13.95	13.95 - 14.04

QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.

Tue, 09 Jun 2026
QuidelOrtho (QDEL) director settles 973 RSUs into common stock award - Stock Titan

Tue, 09 Jun 2026
QuidelOrtho (NASDAQ: QDEL) director gains 2,156 shares via RSU release - Stock Titan

Tue, 09 Jun 2026
QuidelOrtho Corp (QDEL) director gains 1,252 shares from RSU release - Stock Titan

Tue, 09 Jun 2026
QuidelOrtho (QDEL) up 24.1% since last earnings report: Can it continue? - MSN

Mon, 08 Jun 2026
QuidelOrtho Corporation - Common Stock (NQ: QDEL - FinancialContent

Mon, 08 Jun 2026
QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report - Stocktwits

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	68 (M)
Shares Float	62 (M)
Held by Insiders	0.8 (%)
Held by Institutions	124 (%)
Shares Short	11,790 (K)
Shares Short P.Month	11,650 (K)

EPS	-17.86
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	27.19
Profit Margin	-45.6 %
Operating Margin	-4.1 %
Return on Assets (ttm)	0.5 %
Return on Equity (ttm)	-50 %
Qtrly Rev. Growth	-10.5 %
Gross Profit (p.s.)	17.59
Sales Per Share	39
EBITDA (p.s.)	7.21
Qtrly Earnings Growth	0 %
Operating Cash Flow	7 (M)
Levered Free Cash Flow	209 (M)

PE Ratio	-0.79
PEG Ratio	2
Price to Book value	0.51
Price to Sales	0.35
Price to Cash Flow	144.02

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.